Amplyx Pharmaceuticals

Amplyx appoints Ciara Kennedy president and chief executive officer

Monday, January 9, 2017

Amplyx Pharmaceuticals, a company developing novel antifungal agents for life-threatening fungal infections, has announced the appointments of Ciara Kennedy, Ph.D., to president and chief executive officer (CEO) and Karen Joy Shaw, Ph.D., to chief scientific officer (CSO). In conjunction with this announcement, the company’s former president and CEO, Mike Grey, has assumed the role of executive chairman of the Amplyx board of directors. 

[Read More]